UNSPSC 51294412: Trazodone

This classification denotes an antidepressant agent with the molecular formula C19H22ClN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YBK48BXK30, chemically known as 1,2,4-triazolo(4,3-a)pyridin-3(2h)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)- but generally known as trazodone, which bears US NIH Compound Identifier 5533. European Medicines Agency schedules Trazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11224MIG.

UNSPSC 51294412 Trazodone is a Commodity code that encompasses pharmaceutical products for state and local health and emergency services procurement. However, the recent state and local opportunities tagged under this code show a significant mismatch: the single recent solicitation on file is Seminole County, Florida's IFB60459723LAS, which seeks Naloxone and Safe Drug Deactivation Systems — opioid-reversal medications and drug disposal equipment unrelated to trazodone, an antidepressant. The code shows minimal relevant recent activity aligned with its nominal pharmaceutical scope, suggesting either inconsistent coding practices in state and local procurement systems or that trazodone itself generates few direct solicitations at the state and local level.

Seminole County, a Florida county government agency, posted the Naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (an inconsistency in the source data). The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, meet E-Verify and drug-free workplace requirements, maintain workers' compensation and general liability insurance, and accept a three-month probationary termination clause. The contract carries a two-year initial term with a one-year renewal option and potential FEMA funding. Given the single, misaligned solicitation and the absence of trazodone-specific opportunities in the recent record, this code warrants a watch status rather than active pursuit unless additional pharmaceutical procurement activity emerges at other jurisdictions.